Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100


Prognostic significance of CD103+ immune cells in solid tumor: a systemic review and meta-analysis.

Kim Y, Shin Y, Kang GH.

Sci Rep. 2019 Mar 7;9(1):3808. doi: 10.1038/s41598-019-40527-4.


Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.

Koh J, Kim S, Kim MY, Go H, Jeon YK, Chung DH.

Oncotarget. 2017 Feb 21;8(8):13762-13769. doi: 10.18632/oncotarget.14632.


CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma.

Workel HH, Komdeur FL, Wouters MC, Plat A, Klip HG, Eggink FA, Wisman GB, Arts HJ, Oonk MH, Mourits MJ, Yigit R, Versluis M, Duiker EW, Hollema H, de Bruyn M, Nijman HW.

Eur J Cancer. 2016 Jun;60:1-11. doi: 10.1016/j.ejca.2016.02.026. Epub 2016 Mar 31.


CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.

Wang B, Wu S, Zeng H, Liu Z, Dong W, He W, Chen X, Dong X, Zheng L, Lin T, Huang J.

J Urol. 2015 Aug;194(2):556-62. doi: 10.1016/j.juro.2015.02.2941. Epub 2015 Mar 6.


PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer.

Webb JR, Milne K, Nelson BH.

Cancer Immunol Res. 2015 Aug;3(8):926-35. doi: 10.1158/2326-6066.CIR-14-0239. Epub 2015 May 8.


T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?

French JJ, Cresswell J, Wong WK, Seymour K, Charnley RM, Kirby JA.

Br J Cancer. 2002 Oct 21;87(9):1034-41.


Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.

Mann JE, Smith JD, Birkeland AC, Bellile E, Swiecicki P, Mierzwa M, Chinn SB, Shuman AG, Malloy KM, Casper KA, McLean SA, Moyer JS, Wolf GT, Bradford CR, Prince ME, Carey TE, McHugh JB, Spector ME, Brenner JC.

Cancer Immunol Immunother. 2019 Feb;68(2):213-220. doi: 10.1007/s00262-018-2256-3. Epub 2018 Oct 25.


Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer.

Bösmüller HC, Wagner P, Peper JK, Schuster H, Pham DL, Greif K, Beschorner C, Rammensee HG, Stevanović S, Fend F, Staebler A.

Int J Gynecol Cancer. 2016 May;26(4):671-9. doi: 10.1097/IGC.0000000000000672.


Prognostic and therapeutic value of CD103+ cells in renal cell carcinoma.

Zhou J, Liu L, Yang T, Lu B.

Exp Ther Med. 2018 Jun;15(6):4979-4986. doi: 10.3892/etm.2018.6025. Epub 2018 Apr 2.


CD103 and Intratumoral Immune Response in Breast Cancer.

Wang ZQ, Milne K, Derocher H, Webb JR, Nelson BH, Watson PH.

Clin Cancer Res. 2016 Dec 15;22(24):6290-6297. Epub 2016 Jun 7.


CD103 (αE Integrin) Undergoes Endosomal Trafficking in Human Dendritic Cells, but Does Not Mediate Epithelial Adhesion.

Swain S, Roe MM, Sebrell TA, Sidar B, Dankoff J, VanAusdol R, Smythies LE, Smith PD, Bimczok D.

Front Immunol. 2018 Dec 21;9:2989. doi: 10.3389/fimmu.2018.02989. eCollection 2018.


Paxillin Binding to the Cytoplasmic Domain of CD103 Promotes Cell Adhesion and Effector Functions for CD8+ Resident Memory T Cells in Tumors.

Gauthier L, Corgnac S, Boutet M, Gros G, Validire P, Bismuth G, Mami-Chouaib F.

Cancer Res. 2017 Dec 15;77(24):7072-7082. doi: 10.1158/0008-5472.CAN-17-1487. Epub 2017 Oct 11.


Intratumoral immune cells expressing PD-1/PD-L1 and their prognostic implications in cancer: a meta-analysis.

Kim Y, Wen X, Cho NY, Kang GH.

Int J Biol Markers. 2018 May 1:1724600818770941. doi: 10.1177/1724600818770941. [Epub ahead of print]


Prognostic value of high IMP3 expression in solid tumors: a meta-analysis.

Chen L, Xie Y, Li X, Gu L, Gao Y, Tang L, Chen J, Zhang X.

Onco Targets Ther. 2017 Jun 6;10:2849-2863. doi: 10.2147/OTT.S128810. eCollection 2017.


Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.

Webb JR, Milne K, Watson P, Deleeuw RJ, Nelson BH.

Clin Cancer Res. 2014 Jan 15;20(2):434-44. doi: 10.1158/1078-0432.CCR-13-1877. Epub 2013 Nov 4.


The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin.

Corgnac S, Boutet M, Kfoury M, Naltet C, Mami-Chouaib F.

Front Immunol. 2018 Aug 15;9:1904. doi: 10.3389/fimmu.2018.01904. eCollection 2018. Review.


Prognostic value of Kindlin-2 expression in patients with solid tumors: a meta-analysis.

Liu S, Chen S, Ma K, Shao Z.

Cancer Cell Int. 2018 Oct 22;18:166. doi: 10.1186/s12935-018-0651-7. eCollection 2018.


CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients.

Djenidi F, Adam J, Goubar A, Durgeau A, Meurice G, de Montpréville V, Validire P, Besse B, Mami-Chouaib F.

J Immunol. 2015 Apr 1;194(7):3475-86. doi: 10.4049/jimmunol.1402711. Epub 2015 Feb 27.


Role of the mucosal integrin alpha(E)(CD103)beta(7) in tissue-restricted cytotoxicity.

Smyth LJ, Kirby JA, Cunningham AC.

Clin Exp Immunol. 2007 Jul;149(1):162-70. Epub 2007 Apr 2.


The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.

Li J, Wang J, Chen R, Bai Y, Lu X.

Oncotarget. 2017 Feb 28;8(9):15621-15631. doi: 10.18632/oncotarget.14919.

Supplemental Content

Support Center